Weapons of Mass Destruction Events With Contaminated Casualties: Effective Planning for Health Care Facilities
Article Abstract:
Researchers discuss a proposed guideline that health care facilities can use to treat large numbers of patients exposed to a biological weapons attack. Most guidelines for treating such people were created by the military, but these may be inappropriate in a health care setting. The guidelines discuss in detail how to recognize and biological weapons attack, how to protect staff, how to triage and decontaminate patients, and appropriate medical treatments. These efforts must be coordinated with community emergency response teams as well as public health agencies.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Large-Scale Quarantine Following Biological Terrorism in the United States: Scientific Examination, Logistic and Legal Limits, and Possible Consequences. (Special Communication)
Article Abstract:
Quarantining entire populations in the event of a bioterrorism attack may not be necessary and may cause more harm than good in the long term. There are more effective public health measures for limiting the spread of an infectious disease that would not violate civil liberties.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Anthrax as a Biological Weapon: Medical and Public Health Management
Article Abstract:
The report of the Working Group on Civilian Biodefense is presented. The group consisted of 21 representatives from academic medical centers and research, government, military, public health, and emergency management institutions and agencies. Of the various biological agents that could be used as a weapon, the group identified anthrax as the most deadly. After an extensive literature review, the group discusses the epidemiology, pathogenesis, diagnosis and treatment of anthrax. An effective vaccine exists, but it is in short supply and might best be used immediately after exposure.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis
- Abstracts: Policy Analysis of Cervical Cancer Screening Strategies in Low-Resource Settings: Clinical Benefits and Cost-effectiveness
- Abstracts: A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients
- Abstracts: Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy
- Abstracts: Treatment of Acute Hypoxemic Nonhypercapnic Respiratory Insufficiency With Continuous Positive Airway Pressure Delivered by a Face Mask: A Randomized Controlled Trial